Table 2.
Comparison of TREC/KREC levels between ARDS and non-ARDS COVID-19 patients.
| Variable | Non-ARDS (n = 26) | ARDS (n = 10) | p-Value | FDR Adjusted p-Value |
|---|---|---|---|---|
| TREC/100,000 cells | 69.04 (15.43–230.60) | 8.75 (0.00–259.56) | 0.045 | 0.049 |
| TREC/WBC in 1 µL of blood | 4.40 (0.55–11.70) | 0.76 (0.00–13.83) | 0.049 | 0.049 |
| TREC/lymphocytes in 1 µL of blood | 0.09 (0.01–0.33) | 0.01 (0.00–0.34) | 0.026 | 0.039 |
| KREC/100,000 cells | 705.18 (86.64–1532.52) | 160.76 (22.83–537.99) | 0.002 | 0.006 |
| KREC/WBC in 1 µL of blood | 44.64 (5.50–127.93) | 13.57 (2.10–29.74) | 0.003 | 0.006 |
| KREC/lymphocytes in 1 µL of blood | 14.01 (1.99–39.48) | 0.88 (0.23–39.48) | 0.003 | 0.006 |
The data are presented as medians and interquartile range (10–90th percentiles). p-values for the differences between ARDS and non-ARDS patients were obtained from the Mann–Whitney U test.